Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Irbesartan in hypertensive patients with left ventricular hypertrophy.

Next Previous
Trial Profile

Irbesartan in hypertensive patients with left ventricular hypertrophy.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Irbesartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms I-SELECT
  • Sponsors Sanofi

Most Recent Events

  • 07 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 22 Dec 2008 Planned number of patients changed from 418 to 268 as reported by ClinicalTrials.gov.
  • 10 Apr 2008 The expected completion date for this trial is now 1 Jan 2009 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top